Trademark: 79079370
Status Date
Thursday, April 1, 2021
Registration Number
3936764
Registration Date
Tuesday, March 29, 2011
Filing Date
Tuesday, November 10, 2009
Published for Opposition
Tuesday, January 11, 2011
40 Treatment of biopharmaceutical materials, namely, processing finished products from raw biopharmaceutical materials; treatment service of biopharmaceutical materials for others, namely, processing finished products from raw biopharmaceutical materials for others; contract manufacturing service for others in the field of biopharmaceuticals; contract manufacturing service in the field of pharmaceuticals
5 [ Vaccines; medicines for sensory organs, namely, pharmaceutical preparations for the treatment and prevention of disorders of sensory organ; agents affecting peripheral nervous system, namely, pharmaceutical preparations for the treatment and prevention of disorders of the peripheral nervous system; ] agents for immunity adjustment, namely, pharmaceutical preparations for the [ prevention and ] treatment of disorders of the immune system; biological preparations for medical purposes; [ amino acids for medical purposes; antibiotic preparations; agents for respiratory organs, namely, pharmaceutical preparations for the prevention and treatment of disorders of respiratory organs; chemotherapeutics; reagents for measuring Hepatitis B Surface antibody, namely, medical diagnostic reagents for detecting Hepatitis B surface antibody; diagnostic preparations for medical use; AIDS, acquired immune deficiency syndrome diagnostic agents, namely, diagnostic preparation for medical use; AIDS, acquired immune deficiency syndrome vaccines; agents affecting central nervous system, namely, pharmaceutical preparations for the treatment and prevention of disorders of the nervous system; veterinary vaccines; agents for tumor treatment, namely, pharmaceutical preparations for the treatment of tumor; agents for urogenital organs, namely, pharmaceutical preparations for the treatment and prevention of disorders of urogenital organs; kits for protein test, namely, diagnostic kits, namely, primary reagents for detecting the presence of a protein related to a disease; kits for gene test, namely, diagnostic kits, namely, primary reagents for detecting the presence of a gene related to a disease; ] biopharmaceuticals for the treatment [ and prevention ] of [ infectious diseases, tumor-related diseases, ] auto-immune diseases, [ hormone-deficiency diseases; ] biopharmaceutical preparations, namely, polypeptides, proteins, monoclonal antibodies, [ hormones for the treatment and prevention of infectious diseases, tumor-related diseases, auto-immune diseases, hormone deficiency diseases; ] biotherapeutic preparations and substances for medical purposes; biotechnological preparations for medical purposes; pharmaceuticals [ ; chemical preparations for pharmaceutical purposes, namely, chemical reagents for medical purposes; chemico-pharmaceutical preparations ]
35 Wholesale distributorships featuring pharmaceutical products; retail store services featuring pharmaceutical products; business intermediary services in the field of pharmaceutical products; wholesale distributorships featuring biopharmaceutical products; retail store services featuring biopharmaceutical products; business intermediary services in the field of biopharmaceutical products
44 [ Rental of medical and health care equipment; medical product information, namely, providing an interactive holistic web site featuring health information and patient initiated, patient authorized, fee-for-service, holistic approach distance healing sessions based on the patient's specific set of symptoms, medical profile and medical record analysis and patient benefit information concerning organic and holistic products and services; medical clinics, namely, conducting clinical trials of new products for medical purposes; hospitals; medical assistance services; biopharmaceutical consulting service]
42 Pharmaceutical research and development; [ bacteriological research; biological research; research and development for new products for others; material testing; chemistry services, namely, chemistry consultation; chemical research and analysis; technology outsourcing services on biopharmaceuticals manufacturing, namely, conducting biopharmaceutical research services for others; consulting services in the field of biotechnology; pharmaceutical drug development services with animal cell; scientific research related to genetically modified plant; biotechnology research; ] biopharmaceutical research and development [ ; medical product testing; technology outsourcing services on selecting medicines, namely, conducting pharmaceutical research services for others ]
Oct 21, 2023
Change Of Name/Address Rec'd From Ib
Dec 2, 2022
Change Of Name/Address Rec'd From Ib
Jul 9, 2021
New Representative At Ib Received
Jun 12, 2021
Change Of Owner Received From Ib
Apr 1, 2021
Notice Of Acceptance Of Sec. 71 & 15 - E-Mailed
Apr 1, 2021
Registered - Sec. 71 Accepted & Sec. 15 Ack.
Mar 24, 2021
Teas Section 71 & 15 Received
Mar 22, 2021
Applicant/Correspondence Changes (Non-Responsive) Entered
Mar 22, 2021
Teas Change Of Correspondence Received
Mar 22, 2021
Teas Withdrawal As Domestic Representative Received
Mar 22, 2021
Attorney/Dom.Rep.Revoked And/Or Appointed
Mar 22, 2021
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Mar 22, 2021
Teas Change Of Owner Address Received
Mar 29, 2020
Courtesy Reminder - Sec. 71 (10-Yr) E-Mailed
Dec 5, 2019
International Registration Renewed
Apr 6, 2018
Partial Invalidation Processed By The Ib
Feb 22, 2018
Partial Invalidation Of Reg Ext Protection Sent To Ib
Feb 22, 2018
Invalidation Processed
Feb 15, 2018
Partial Invalidation Of Reg Ext Protection Created
Jun 15, 2017
Notice Of Acceptance Of Sec. 71 - E-Mailed
Jun 15, 2017
Registered - Partial Sec 71 Accepted
Jun 15, 2017
Case Assigned To Post Registration Paralegal
Mar 28, 2017
Teas Section 71 Received
Mar 26, 2015
Change Of Name/Address Rec'd From Ib
Feb 25, 2013
Final Decision Transaction Processed By Ib
Jun 12, 2012
Limitation From The Ib Examined, No Action Is Needed
May 25, 2012
Limitation Of Goods Received From Ib
Jun 30, 2011
Final Disposition Notice Sent To Ib
Jun 30, 2011
Final Disposition Processed
Jun 29, 2011
Final Disposition Notice Created, To Be Sent To Ib
Mar 29, 2011
Registered-Principal Register
Jan 11, 2011
Official Gazette Publication Confirmation E-Mailed
Jan 11, 2011
Published For Opposition
Dec 7, 2010
Law Office Publication Review Completed
Dec 7, 2010
Assigned To Lie
Nov 15, 2010
Approved For Pub - Principal Register
Nov 12, 2010
Teas/Email Correspondence Entered
Nov 11, 2010
Correspondence Received In Law Office
Nov 11, 2010
Teas Response To Office Action Received
Nov 11, 2010
Teas Change Of Correspondence Received
May 12, 2010
Notification Of Non-Final Action E-Mailed
May 12, 2010
Non-Final Action E-Mailed
May 12, 2010
Non-Final Action Written
May 10, 2010
Teas Change Of Correspondence Received
May 10, 2010
Teas/Email Correspondence Entered
May 10, 2010
Correspondence Received In Law Office
May 10, 2010
Teas Response To Office Action Received
Apr 19, 2010
Undeliverable Mail - No Action Taken
Apr 9, 2010
Refusal Processed By Ib
Mar 19, 2010
Application Filing Receipt Mailed
Mar 17, 2010
Non-Final Action Mailed - Refusal Sent To Ib
Mar 17, 2010
Refusal Processed By Mpu
Mar 17, 2010
Non-Final Action (Ib Refusal) Prepared For Review
Mar 16, 2010
Non-Final Action Written
Mar 15, 2010
Assigned To Examiner
Mar 15, 2010
New Application Office Supplied Data Entered
Mar 11, 2010
Sn Assigned For Sect 66a Appl From Ib
Trademark Alertz updated from USPTO on 2030-01-24
